相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhibition of S6K1 accounts partially for the anti-inflammatory effects of the arginase inhibitor L-norvaline
Xiu-Fen Ming et al.
BMC CARDIOVASCULAR DISORDERS (2009)
Drug-eluting stent and coronary thrombosis -: Biological mechanisms and clinical implications
Thomas F. Luescher et al.
CIRCULATION (2007)
Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways
L. Liu et al.
ONCOGENE (2006)
Rapamycin, but not FK-506, increases endothelial tissue factor expression -: Implications for drug-eluting stent design
J Steffel et al.
CIRCULATION (2005)
Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF
M Guba et al.
BLOOD (2005)
Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control
M Ohanna et al.
NATURE CELL BIOLOGY (2005)
Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase
H Viswambharan et al.
CIRCULATION RESEARCH (2004)
Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells
T Ishibashi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells
XF Ming et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
DC Fingar et al.
GENES & DEVELOPMENT (2002)
Statin prevents tissue factor expression in human endothelial cells -: Role of Rho/Rho-kinase and Akt pathways
M Eto et al.
CIRCULATION (2002)
Tissue factor and coronary artery disease
AHM Moons et al.
CARDIOVASCULAR RESEARCH (2002)
TOR, a central controller of cell growth
T Schmelzle et al.
CELL (2000)